gbt021601
global blood therapeutics
['gbt021601']
next gen #polymerisation inhibitor: loading and maintenance dose of 50 mg &amp; 100 mg #gbt021601 achieved steady-state drug concentration corresponding to improvements in hemoximetry &amp; ektacytometry in #adults with #sicklecell dr idowu #ash22 
Haematologist, red cell disorders and marrow failure. Working towards definitive cure: #BMT #genetherapy. @ImperialNHS @ImperialImmuno @TheEBMT @ApothecariesLDN